Q2 2023 Holdings
Filed 2023-08-04 | 56 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| UiPath Inc(PATH) | CL A | 90364P105 | $233.1M | 14,068,674 | 12.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $197.8M | 10,549,086 | 10.6% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $193.8M | 24,042,864 | 10.4% |
| Crowdstrike Hldgs Inc(CRWD) | CL A | 22788C105 | $188.5M | 1,283,683 | 10.1% |
| Prime Medicine, Inc.(PRME) | COM | 74168J101 | $173.8M | 11,862,498 | 9.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $155.9M | 1,212,806 | 8.4% |
| Gitlab Inc.(GTLB) | CLASS A COM | 37637K108 | $135.3M | 2,647,312 | 7.3% |
| Planet Labs Inc.(PL) | COM CL A | 72703X106 | $102.9M | 31,942,641 | 5.5% |
| Snowflake Inc(SNOW) | CL A | 833445109 | $94.3M | 535,604 | 5.1% |
| Eqrx Inc | COM | 26886C107 | $88.7M | 47,675,476 | 4.8% |
| Freshworks Inc(FRSH) | CLASS A COM | 358054104 | $70.9M | 4,035,595 | 3.8% |
| Lyft Inc(LYFT) | CL A COM | 55087P104 | $35.5M | 3,702,054 | 1.9% |
| Benson Hill Inc. | COMMON STOCK | 082490103 | $20.0M | 15,352,271 | 1.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $19.7M | 1,568,753 | 1.1% |
| Desktop Metal Inc. | COM CL A | 25058X105 | $19.6M | 11,048,730 | 1.1% |
| Lyell Immunopharma Inc. | COM | 55083R104 | $18.7M | 5,865,125 | 1.0% |
| Sana Biotechnology Inc.(SANA) | COM | 799566104 | $16.8M | 2,812,500 | 0.9% |
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $10.3M | 321,604 | 0.6% |
| Rapt Therapeutics Inc.(RAPTEUR) | COM | 75382E109 | $10.1M | 540,270 | 0.5% |
| Monte Rosa Therapeutics Inc.(GLUE) | COM | 61225M102 | $10.0M | 1,464,015 | 0.5% |
| Illumina Inc.(ILMN) | COM | 452327109 | $10.0M | 53,470 | 0.5% |
| Decibel Therapeutics Inc. | COM | 24343R106 | $6.3M | 1,636,258 | 0.3% |
| Robinhood Mkts Inc(HOOD) | COM CL A | 770700102 | $6.1M | 612,214 | 0.3% |
| Invivyd Inc.(IVVD) | COM | 00534A102 | $6.0M | 5,680,785 | 0.3% |
| Tenaya Therapeutics Inc.(TNYA) | COM | 87990A106 | $5.4M | 915,705 | 0.3% |
| Vera Therapeutics Inc.(VERA) | CL A | 92337R101 | $4.8M | 301,580 | 0.3% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $3.5M | 500,901 | 0.2% |
| Vaccitech PLC(BRNS) | ADS | 91864C107 | $3.1M | 1,513,644 | 0.2% |
| Tscan Therapeutics Inc.(TCRX) | COM | 89854M101 | $2.7M | 1,077,080 | 0.1% |
| Magenta Therapeutics Inc. | COM | 55910K108 | $2.5M | 3,339,138 | 0.1% |
| Kronos Bio Inc.(KRON1USD) | COM | 50107A104 | $2.5M | 1,438,232 | 0.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $2.2M | 23,205 | 0.1% |
| Hyperfine Inc.(HYPR) | COM CL A | 44916K106 | $1.9M | 898,720 | 0.1% |
| Rani Therapeutics Hldgs Inc.(RANI) | COM CL A | 753018100 | $1.8M | 448,492 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADR | 05280R100 | $1.7M | 698,262 | 0.1% |
| Spero Therapeutics Inc.(SPRO) | COM | 84833T103 | $1.3M | 889,979 | 0.1% |
| Alector Inc.(ALEC) | COM | 014442107 | $1.1M | 175,866 | 0.1% |
| Science 37 Holdings Inc. | COM | 808644108 | $673.5K | 3,207,260 | 0.0% |
| Oportun Finl Corp(OPRT) | COM | 68376D104 | $565.9K | 94,788 | 0.0% |
| Taysha Gene Therapies Inc.(TSHA) | COM SHS | 877619106 | $423.0K | 640,882 | 0.0% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A107 | $285.6K | 189,122 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $266.2K | 235,606 | 0.0% |
| Evelo Biosciences Inc.(EVLO) | COM NEW | 299734202 | $172.3K | 53,024 | 0.0% |
| Mondee Holdings Inc.(MONDQ) | CLASS A COM | 465712107 | $164.1K | 18,420 | 0.0% |
| Repligen Corp(RGEN) | COM | 759916109 | $54.2K | 383 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $47.1K | 14,262 | 0.0% |
| Cue Health Inc(HLTHQ) | COM | 229790100 | $10.0K | 27,000 | 0.0% |